IL-10, originally isolated from mouse helper T cells, is a cytokine with regulatory functions on a number of interleukins. In this study we show that recombinant human IL-10 affects the expression of several genes involved in extraceliular matrix synthesis and remodeling in human dermal fibroblast cultures. As judged by Northern blot analyses, type I collagen gene expression was downregulated, while collagenase and stromelysin gene expression were markedly enhanced by IL-10. No effect on tissue inhibitor of metalloproteases mRNA levels was noted. Transient transfections of skin fibroblasts with type I collagen promoter/chloramphenicol acetyl transferase reporter gene constructs showed downregulation by IL-10, suggesting inhibition at the transcriptional level. When compared with control cultures, incubation with IL-10 resulted in a decrease in immunostaining of fibroblast cultures with antibodies to human type I collagen. In contrast, immunostaining of such IL-10-treated cultures with antibodies to human coliagenase resulted in an increase in immunostaining. This study suggests a role for IL-10 in the breakdown and remodeling of the extracellular matrix. (J. Clin. Invest. 1994. 94:2489-2492
Introduction
Interleukin-10 (IL-10) is a 18.5-kD polypeptide which was originally characterized as a cytokine secreted by activated mouse T helper (Th2)' cell clones (1) . It inhibits synthesis of several cytokines by T lymphocytes and activated monocytes and was therefore originally named cytokine synthesis inhibitory factor (1) . Specifically, IL-10 suppresses the production of IL-2 and IFN-y, as well as other cytokines by Thl cells and macrophages (1) (2) (3) . It also inhibits antigen-specific proliferation of ThI cells (4) . In humans, IL-10 is produced, in addition to T cells, by activated monocytes (5) , and in contrast to mouse 1. Abbreviations used in this paper: AP, activator protein; CAT, chloramphenicol acetyl transferase; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; Th, T helper; TIMP, tissue inhibitor of metalloprotease.
T cells also by various T cell subsets, including ThO, Thl, and Th2 cell clones (6, 7) .
The interactions of IL-10 with other cytokines have been studied in considerable detail in human monocytes. For example, IL-10 is a powerful suppressor of the synthesis of IL-la, IL-1,6, IL-6, IL-8, TNF-a, and granulocyte macrophage and granulocyte colony-stimulating factor by activated monocytes (4, 8) . Human IL-1O also reduces antigen-specific proliferation of human T cells (5) . Collectively, these previous studies indicate that the effects of IL-10 in monocytes and T cells are mainly downregulatory.
Little information is available on the effects of IL-10 on connective tissue cells. In this study we report that recombinant human IL-10 modulates expression of the genes involved in extracellular matrix synthesis and breakdown in human dermal fibroblasts in vitro.
Methods
Cell cultures. Adult human skin fibroblast cultures, established from tissue specimens obtained during cosmetic surgery, and neonatal foreskin fibroblast cultures were used in passages 4-10. Cells were maintained in Dulbecco's modified Eagle's medium (DME) supplemented with 10% FCS, 2 mM glutamine, 50 ,g/ml streptomycin, and 50 U/ml penicillin.
Preparations of IL-JO. Recombinant human IL-10 (molecular mass 18.5 kD) obtained from PeproTech, Inc. (Rocky Hill, NJ) in lyophilized form was dissolved in water, and further dissolved in DME containing 1% FCS. For cell cultures, IL-10 was used at varying concentrations, ranging from 0.1 to 100 ng/ml. Northern analyses. Total RNA was isolated from confluent fibroblast cell cultures (9, 10) (11) . After hybridizations at 42'C for 18 h, the filters were washed in solutions with decreasing ionic strength and increasing temperature, and the final stringency of the washes was 0.1 x standard saline citrate and 0.1% SDS, at 65°C. The radiolabeled cDNA-mRNA hybrids were visualized by autoradiography, and the corresponding steady-state levels of mRNA were quantitated by using a laser densitometer (Ultroscan XL; LKB Instruments, Inc., Bromma, Sweden). The following cDNAs were used for Northern hybridizations: for proal (I) collagen mRNA, a 1.5-kb human cDNA (12) ; for proa2(I) collagen mRNA, a 2.9-kb human cDNA (13) ; for collagenase, a 2.3-kb human type I collagenase cDNA ( 14) ; for stromelysin-1, a 1.8-kb human cDNA (15) ; for tissue inhibitor of metalloprotease-1 (TIMP-1), a 0.7-kb human cDNA (kindly provided by Dr. D. Carmichael, Synergen, Boulder, CO) and a 1.3-kb rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA (pRGAPDH13) (16) [14C] chloramphenicol by thin-layer chromatography is shown. Relative promoter activity decreased with IL-10 in concentration 0.1 ng/ml to 55%, with I ng/ml to 52%, and with 10 ng/ml to 37% from the activity noted in untreated cells, respectively. Cultures of fibroblasts were incubated without (A) or with IL-O0 ( 1 ng/ ml) (B) for 72 h in medium containing 1% FCS. For indirect immunofluorescence, the cells were fixed in cold ethanol before immunolabeling with antibodies to human type I collagen. 100 ng/ml. As compared with control cultures without IL-10, incubation of the cells with IL-1O resulted in marked downregulation of type I (both proal and proa2 chain) collagen mRNA steady-state levels (Fig. 1) . However, IL-10 caused enhancement of both collagenase and stromelysin mRNA steady-state levels over the wide range of IL-10 concentrations used (Fig.  1 ). IL-10 had no effect on TIMP gene expression (Fig. 1) .
The time course of type I collagen, collagenase, and stromelysin mRNA expression was determined by Northern analysis of fibroblasts exposed to 1 ng/ml IL-10 for different time periods. The collagenase and stromelysin mRNA levels showed maximum enhancement after 12 h of exposure to IL-1O, and the levels were reduced at 24 h (Fig. 2) . However, the maximum reduction of type I collagen (a2(I)) mRNA levels was seen after 24 h of exposure (Fig. 2) .
Evidence of transcriptional inhibition of type I collagen gene expression by IL-10. Transient transfections of human foreskin fibroblasts with a human a2(I) collagen promoter/ CAT reporter gene construct showed downregulation by IL-10 ( Fig. 3) , suggesting a transcriptional effect of IL-10 on type I collagen gene expression. In contrast, IL-10 did not modulate the activities of collagenase promoter/CAT reporter gene construct or the construct pAPCAT2a, suggesting that the regulation of collagenase gene expression by IL-1O was not transcriptional and that IL-10 does not affect AP-1 expression. Parallel transfections done with the SV2 promoter/CAT showed no effect of IL-10. IL-IO reduces type I collagen and increases procollagenase protein in cultured dermal fibroblasts. Human skin fibroblasts in culture have been shown to synthesize precursors of both type I collagen and collagenase proteins which are secreted. To evaluate semiquantitatively the effects of IL-10 on type I collagen and collagenase expression at the protein level, human skin fibroblast cultures maintained in 1% FCS were incubated in the presence of IL-10 (1 ng/ml). When compared with control cultures incubated without IL-10, incubation with IL-10 resulted in decreased immunolabeling of cells for type I collagen, suggesting decreased procollagen protein synthesis (Fig. 4) . In contrast, immunostaining with an antiserum to human procollagenase resulted in increased immunolabeling for procollagenase protein in human skin fibroblast cultures, suggesting increased procollagenase protein synthesis or decreased breakdown as a result of IL-10 treatment (Fig. 5) .
Discussion
Earlier studies on IL-10 have mainly concentrated on its effects in various immunocompetent cells such as T lymphocytes and monocytes (20) . In the present study, we show that IL-10 has additional effects in human dermal fibroblasts. One of these effects is transcriptional inhibition of type I collagen expression. This collagen is the major component of the extracellular matrix in human skin (21 polypeptides, namely al (I) and a2(I), and regulation of al (I) and a2 (I) expression is coordinate (22). Several responsive elements in the promoter region of these genes have been identified, including NF-1, NF-KB, and AP-2 (23) . The effects of IL-10 on type I collagen gene expression could either be due to direct effects on such responsive elements or mediated by effects of IL-10 on other cytokines.
In contrast to type I collagen gene, transient transfections with collagenase reporter gene construct revealed no evidence of transcriptional control of the collagenase gene, suggesting that the observed effects of 1L-10 on mRNA steady-state levels could be due to posttranscriptional mechanisms. The collagenase gene contains several AU-rich sequences, which are thought to be involved in posttranscriptional modulation mRNAs (24) .
The present findings could have in vivo relevance. While it is not clear whether dermal fibroblasts express EL-10, there are cells in normal skin capable of IL-10 expression and secretion. As shown recently by Enk and Katz (25) , murine keratinocytes secrete IL-10 when appropriately stimulated. An in vivo situation in which IL-10 induction could play a role is the exposure to ultraviolet (UV) radiation. Such an exposure has been shown to result in impairment of delayed type hypersensitivity which has been shown to be at least in part mediated by 1L-10 (26). Chronic exposure to UV leads additionally to changes in the composition of the matrix molecules, mainly to a decrease in the amount of collagen and an increase in the amount of elastic fibers in the dermis. Induction of collagenase and stromelysin in vivo would result in a decrease of type I collagen, which is the main component of the dermis. This study shows, however, that IL-10 has an effect on type I collagen gene expression. Of interest, we have shown recently that, in a transgenic mouse model transfected with a human elastin promoter/CAT construct, IL-10 induces the elastin promoter activity in dermal fibroblasts (27) . Taken together, these results suggest that 1L-10 may be involved in the pathogenesis of UV-induced changes in the dermis.
In conclusion, IL-10, among several other cytokines such as IL-1, TNF-a, and TGF-f3, is probably involved in the regulation of type I collagen synthesis and degradation.
